key: cord-0035524-0urt7axu authors: Li, Yun; Lavi, Ehud title: The Role of Astrocytes, Microglia, and Endothelial Cells in Coronavirus-Induced Demyelination: Induction of cytokines and other signaling mechanisms date: 2005 journal: Experimental Models of Multiple Sclerosis DOI: 10.1007/0-387-25518-4_38 sha: ddee2cd2eabbb20661907b57c7f8510c86466319 doc_id: 35524 cord_uid: 0urt7axu Infection of neurotropic strains of coronaviruses in susceptible animals results in acute encephalomyelitis followed by a chronic demyelinating disease, similar to multiple sclerosis (MS). Although the mechanism of chronic coronavirus-induced demyelination is not entirely clear, studies show that it is mostly immune-mediated. Astrocytes, microglia and endothelial cells play an important role in normal functions as well as in immunologic and pathologic processes in the central nervous system (CNS). The interaction between coronaviruses and these cells induces various inflammatory mediators including cytokines, chemokines, MHC and NO, which acting in concert are involved in the pathogenesis of demyelination. Astrocytes, microglia and endothelial cells play an important role in the pathogenesis of coronavirus, mouse hepatitis virus (MHV)-induced disease in mice in several ways. All three cell-types are targets to various degrees of MHV infection during acute and chronic disease. Secondly, astrocytes and microglia are also targets of apoptotic cell death, presumably as a direct consequence of infection. In addition, astrocytes and microglia serve as reactive proliferating cells, as normally seen in viral encephalitis and other types of CNS injury. Finally all three cell-types are considered part of the CNS innate immune system, and as such are responsible for pro- Chapter C2 inflammatory immune reactions. These reactions involve secretory functions of a variety of pro-inflammatory molecules including cytokines, chemokines, upregulation of major histocompatibility complex (MHC) and NO molecules and a variety of downstream signal transduction and related molecules. CNS disease, especially demyelination could be a result of a combination of viral cytopathic effect on cells and the secondary pathologic effect of toxic inflammatory mediators, thus fulfilling the concept of autoimmunity. Indirect proof for this concept comes from studies in which immuno-suppression ameliorated chronic MHV-induced demyelination. In the following paragraphs we will briefly review the normal functions of astrocytes, microglia and endothelial cells and evaluate how these functions are affected in relationship to the pathogenesis of virus-induced CNS disease. Historically two groups of glial cells were identified in the CNS: the macroglia, including astrocytes, oligodendrocytes, and ependymal cells, and microglia. More recently microglial cells have been identified as bone marrow derived and not of neuroectodermal origin, and therefore cannot be considered as true glial cells. Astrocytes, the main CNS glial cells have a number of important physiological properties related to CNS homeostasis. Astrocytes have a dynamic role in regulating neuronal function (Sofroniew et al. 1999; Haydon 2000) by the release of neurotrophic factors, guidance of neuronal development, contributing to the metabolism of neurotransmitters, and regulating extracellular pH and K + levels. Astrocytes influence the formation and maintenance of the blood-brain barrier (BBB), a structure that serves to limit entry of blood-borne elements into the CNS. Astrocytic foot processes are in close apposition to the abluminal surface of the microvascular endothelium of the BBB, and soluble factors secreted by astrocytes appear to be involved in the maintenance of the BBB. Thus, astrocytes contribute to both the structural and functional integrity of the BBB (Wolburg-H 1995) . Astrocytes also serve as one of the immune effecter cells in the CNS. Astrocytes play a significant role during infectious and autoimmune diseases of the CNS. As part of the BBB, astrocytes are in close proximity to endothelial cells and secrete cytokines, chemokines and adhesion molecules (Lee et al. 2000) . Cultured astrocytes express a wide range of molecules with neurotropic properties such as nervous growth factor (NGF), glialderived growth factor (GDGF), and ciliary neurotropic factor (CNTF). In response to activation by intefferons astrocytes express class I and class II MHC antigens. The expression of the costimulatory molecules B7 and Microglia constitutes 12% of the cells in the CNS, which are the principal immune cells in the CNS and play a significant role in the host defense against invading microorganisms. The CNS endogenous microglia share many properties with macrophages, having developed from a common precursor cells (Nelson et al. 2002) . Features common to microglia and systemic macrophages include the expression of innate immune receptors and the ability to phagocytose pathogens, cells or cellular debris (Ling and Wong 1993; Williams et al. 1994) . The functions of microglia in the CNS include phagocytosis, antigen presentation, production and release of cytokines, eicosanoids, complement components, and excitatory amino acids such as glutamate, oxidative radicals, and nitric oxide (Gehrmann et al. 1995) . Three states of microglia have been identified based on developmental and pathophysiologic studies: (1) the resting, ramified microglia present in normal CNS; (2) the activated non-phagocytic microglia found in areas involved in CNS inflammation (3) the reactive, phagocytic microglia observed in areas of trauma and infection. Microglia can express class I and II MHC antigens, Fc receptors (I-III), complement receptors (CR1, CR2, CR4), [32-integrins, intercellular adhesion molecule-1 (ICAM-1), and costimulatory molecules B7-1 and B7-2 (Minagar et al. 2002) . Numerous studies have confirmed the role of microglia as important APCs within the CNS (Aloisi et al. 2000; Becher et al. 2000) , while the role of astrocytes remains controversial. Traditionally, the CNS has been regarded as an immunologically privileged site. The CNS lacks lymphatic vessels and is sealed by the BBB. The cellular basis for the BBB is at the levels of both the CNS microvascular endothelial cells and the choroid plexus epithelial cells. The BBB is an important mechanism for protecting the brain from fluctuations in plasma composition and from circulating agents such as neurotransmitters and xenobiotics capable of disturbing neural function (Abbott and Romero 1996) . The barrier also plays an important role in the homeostatic regulation of the brain microenvironment necessary for the stable and coordinated activity of neurons (Abbott 2002) . The brain endothelium has lower levels of endocytosis/transcytosis than peripheral capillaries, but has a number of specific transport and enzyme systems, which regulate molecular traffic across the endothelial cells. The brain endothelium also contains specific enzymatic systems such as monoamine oxidase that support the protective and detoxifying roles of the BBB. Cerebral microvascular endothelial cells are also considered as potential APCs because of their large cumulative surface and their unique anatomical location between circulating T cells and the extra-vascular sites of antigen exposure. Thus BBB covers a number of static and dynamic properties that enable the endothelium to protect and regulate the brain microenvironment (Abbott and Romero 1996) . The BBB phenotype develops under the influence of associated brain cells, especially astrocytes. In vitro cell culture models have provided a great deal of information about the key role of astrocytes in the induction of the BBB phenotype in brain endothelium (Bauer and Bauer 2000) . The chemical nature of the glial-produced inductive signal(s) is currently unclear. TGF-13 (Tran et al. 1999) , GDNF (Utsumi et al. 2000) , bFGF (Sobue et al. 1999 ), IL-6 and hydrocortisone (Hoheisel et al. 1998 ) have been shown to modulate endothelial differentiation and induction. In addition to a role in barrier induction and maintenance, astrocytes may play active roles in modulating BBB permeability by the release of several humoral agents including glutamate, aspartate, taurine, ATP, ET-1, NO, TNF~, MIP2 and IL-1 ~, although the regulation of this release is not well understood (Abbott 2002) . Interestingly, it has recently been shown that endothelial cells induce the differentiation of astrocyte precursor cells into astrocytes in vitro, which is mediated by endothelial cell production of leukemia inhibitory factor (LIF) (Mi et al. 2001) . Thus endothelium and astrocytes are involved in two-way induction. It is clear that endothelial cells are involved in both long-and short-term chemical communication with neighboring cells, with astrocytes being of particular importance. Maintenance of the adult BBB appears to depend on continuing exchange of inductive signals between glia and endothelium, and disturbance of this induction may be instrumental in several neuropathologies involving BBB dysfunction, such as tumors and MS. Coronaviruses constitute a large group of positive-stranded RNA viruses that are associated with a wide variety of respiratory, gastrointestinal, and neurological diseases in animals and humans. However there is no conclusive evidence that any human neurological diseases, such as MS, may occur as a result of human coronavirus infection. MS is an inflammatory demyelinating disease of the CNS that is characterized by mononuclear cell infiltration into the CNS, myelin degradation and oligodendrocyte loss. It is the most common neurological disease affecting young adults (Ewing and Bernard 1998) . The etiology and pathogenesis of MS have yet to be elucidated but are probably multifactorial, involving both genetic and environmental factors (Ewing and Bernard 1998) . Several viruses have been associated with demyelinating processes including human coronaviruses (HCoV) and murine coronavirus (MHV). Intracerebral infection of susceptible mice with neuroadapted strains of mouse hepatitis virus (MHV) results in an acute encephalomyelitis followed by a chronic demyelinating disease similar to the pathology of the human MS (Lavi et al. 1984; Lavi et al. 1986; Lane and Buchmeier 1997) , serving as models for this diseases. The two strains of MHV that have been used in the majority of studies of MHV infection in the CNS are MHV-A59 and JHM (MHV-4). The mechanism of MHV induced demyelination is still not well understood. Although it was initially believed to result from direct viral lysis of oligodendrocytes, chronic demyelination was demonstrated to be largely immune mediated in more recent reports. The immune response to MHV infection is critical in host defense as well as the development of demyelination Wu et al. 2000) . However, the precise role of individual components of the immune system in this process is not known and need intense investigation. The fact that the nude mice were unable to clear virus and still develop demyelination suggests that conventionally educated T cells are not an essential component for demyelination. That means that either the 78 subset of T cells, natural killer cells, or microglia, astrocytes, or even endothelial cells, may participate and/or be responsible for the demyelinating process. To protect the host from the invasion of foreign organisms and pathogenic insults, the immune system has evolved into two parts: one is responsible for immediate, relatively generic, action against external agents, known as the "the innate immune system". The other component of the immune system responds specifically to an external threat and requires plasticity and memory, which is called the "adaptive or acquired immune system". These two systems are not separate, but are functionally intertwined and the actions of one have a profound effect on the other (Medzhitov and Janeway 1997) . B and T lymphocytes are the cellular members of the adaptive immune system. These cells are generated in primary lymphoid tissues (bone marrow, thymus) and re-circulated in secondary lymphoid structures (lymphnode, spleen). The innate immune system on the other hand uses mainly phagocytic cells (including monocytes/macrophages, and polymorphonuclear phagocytes) as a first line of defense against foreign structures. Astrocytes and microglia are the principal innate immune cells in the CNS concomitant with inflammatory brain disease and play a significant role in the host defense against invading microorganisms. Although the CNS has been characterized as an immune privileged site, it is also the site of blood-borne inflammation, either in response to exogenous antigens (infection) or as a result of disrupted peripheral tolerance to self antigens (autoimmnunity). The microenvironment of the CNS, shaped by its structural and cellular components, participates in the physiological immune process that occurs within the CNS and is at least in part responsible for the extent of immune response within the CNS upon viral infections. Glial and microglial cells play a pivotal role in both acute and chronic phases of coronavirus infection, which could lead to the production of a variety of inflammatory molecules in glial cells including cytokines, chemokines, MHC and nitric oxide (NO) that have been associated with the pathogenesis of demyelination. The MHC class I and II antigens play an important role in demyelination following infection by MHV of resident cells of the CNS. Infection of the CNS with MHV-A59, a neurotropic murine coronavirus, induces class I MHC antigen expression on oligodendrocytes and astrocytes (Suzumura et al. 1986; Suzumura et al. 1988; Lavi et al. 1989) , cells that do not normally express detectable MHC surface antigens. The role of MHC class I in demyelination remains complex because of reports indicating that demyelination can occur in MHV-infected mice that lack either stable C2. The Role of Astrocytes, Microglia, and Endothelial Cells In Coronavirus induced demyelination 723 expression of the MHC class 1 molecule or functional CD8+ T cells (Gombold et al. 1995) . Because MHC class I antigens play a key role in interaction between cytotoxic T cells and target cells, the induction of MHC class I antigens could potentially allow gliai cells to interact with or become a target for immunocytes. The MHC class 11 molecules play a critical role in induction of immune responses through presentation of processed antigens to CD4 + T-helper cells. Although class II MHC molecules are essential for lymphocyte development, antigen presentation, and T-cell activation, inappropriate class II expression has been implicated in several autoimmune diseases, including rheumatoid arthritis, inflammatory bowel disease, and MS (Grusby and Glimcher 1995) . Class II MHC molecules are normally expressed on professional APCs, such as B cells, macrophages, dendritic cells, and thymic epithelium, expression on other cell types, including astrocytes, can be induced and/or regulated by cytokines, neurotransmitters, and neuropeptides. Astrocytes were the first CNS cell type shown to express class II MHC molecules upon IFN-7 stimulation in vitro (Wong et al. 1984) . The cytokine TNF-a, while having no influence alone on class II MHC expression, enhances IFN-7-induced class 11 MHC expression on astrocytes (Panek et al. 1994) . Infection of astrocyte cultures derived from MHV-susceptible Lewis rats with MHV-JHM resulted in induction of MHC class II, whereas no such induction was observed in astrocytes from disease-resistant Brown Norway rats . A number of soluble mediators have been shown to inhibit class 11 MHC expression in astrocytes, which include TGF-13, IL-113, IFN-13, IL-4, glutamate, vasoactive intestinal peptide, norepinephrine, and nitric oxide (Rohn et al. 1996) . The expression of MHC II on phagocytic microglia implies the capacity of microglia as APCs. Phagocytic microglia is often regarded as potentially cytotoxic in both acute and chronic CNS disorders. MHC class 11 expression by phagocytic microglia also corresponds to the elevated expression of potentially cytotoxic substances in the CNS, among which nitric oxide and TNF-~ are notably involved in the death of oligodendrocytes and demyelination (Benveniste 1997; Eugster et al. 1999) . A study on the demyelinating twitcher mouse has shown that the number of reactive microglia and the concomitant demyelination is significantly reduced when the twitcher mouse carries an MHC 11 null background (Matsushima et al. 1994 ). Therefore, MHC 11 expression by activated microglia in chronic neurodegenerative disorders may indicate that the activated microglia become cytotoxic (Zhang et al. 2001 ). Expression of MHC class II has been shown to be important in demyelinating disease in some animal models, such as TMEV and EAE (Borrow and Nash 1992) . However, mice deficient in MHC class 1I expression are capable of having demyelination following infection with MHV-JHM . Therefore, the expression of MHC class I or II may play some role in the MHV-induced demyelination, but neither one is absolutely necessary for this process. Astrocytes and microglia produce a variety of cytokines and chemokines upon stimulation with a variety of factors including viral infection. Although expression of cytokines and chemokines is controlled and balanced in the normal, healthy, CNS, aberrant expression occurs in CNS diseases such as AD, MS, HAD, Parkinson's disease, and in brain injury/trauma. In many of these diseases, astrocytes and microglia are responsible for some of the production of cytokines and chemokines, whereas blood-borne inflammatory cells are responsible for the rest. Both in vitro and in vivo studies have documented the ability of astrocytes to produce interleukin-1, -6, and -10 (IL-1, -6, and -10); interferon (IFN)-a, and -[3; colony-stimulating factors GM-CSF, M-CSF, and G-CSF; TNF-a; TGF-[3; and chemokines including RANTES, IL-8, monocyte chemoattractant protein-1 (MCP-1), and IFN-7-inducible protein-10 (IP-10) (Dong and Benveniste 2001) . Cytokines that have been demonstrated to be produced by microglia are IL-1, 2, 3, 4, 6, 8, 10, IFN-~, TNF